US Stock MarketDetailed Quotes
TCRT Alaunos Therapeutics
- 3.1474
- -0.0426-1.34%
Trading Aug 27 09:52 ET
5.04MMarket Cap-262P/E (TTM)
3.2503High2.9600Low15.29KVolume3.2500Open3.1900Pre Close48.62KTurnover1.17%Turnover RatioLossP/E (Static)1.60MShares32.850052wk High1.34P/B4.12MFloat Cap2.110052wk Low--Dividend TTM1.31MShs Float36000.0000Historical High--Div YieldTTM9.10%Amplitude2.1100Historical Low3.1800Avg Price1Lot Size
Alaunos Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -86.55%2.46M | -82.36%4.15M | -84.48%6.06M | -84.48%6.06M | -68.41%11.94M | -69.48%18.32M | -65.58%23.5M | -48.64%39.06M | -48.64%39.06M | -58.78%37.81M |
| -Cash and cash equivalents | -86.55%2.46M | -82.36%4.15M | -84.48%6.06M | -84.48%6.06M | -68.41%11.94M | -69.48%18.32M | -65.58%23.5M | -48.64%39.06M | -48.64%39.06M | -58.78%37.81M |
| Receivables | 0.00%4K | --1K | -75.00%1K | -75.00%1K | --0 | --4K | --0 | -99.64%4K | -99.64%4K | 92.78%2.91M |
| -Accounts receivable | 0.00%4K | --1K | -75.00%1K | -75.00%1K | --0 | --4K | --0 | -99.64%4K | -99.64%4K | 92.78%2.91M |
| Restricted cash | ---- | ---- | --0 | --0 | --0 | --0 | --13.94M | --13.94M | --13.94M | --13.94M |
| Other current assets | 383.81%2.21M | 152.13%1.89M | 175.09%2.2M | 175.09%2.2M | 8.95%925K | -66.15%457K | -50.56%750K | -52.04%799K | -52.04%799K | -74.42%849K |
| Total current assets | -75.09%4.68M | -84.19%6.04M | -84.64%8.26M | -84.64%8.26M | -76.81%12.87M | -69.40%18.78M | -45.27%38.18M | -31.75%53.8M | -31.75%53.8M | -42.51%55.51M |
| Non current assets | ||||||||||
| Net PPE | --0 | --0 | -99.98%2K | -99.98%2K | -41.83%6.57M | -28.10%8.65M | -31.88%9.91M | -31.02%10.6M | -31.02%10.6M | -32.92%11.3M |
| -Gross PPE | ---- | ---- | -99.93%15K | -99.93%15K | -41.83%6.57M | -28.10%8.65M | -31.88%9.91M | -10.41%20.4M | -10.41%20.4M | -32.92%11.3M |
| -Accumulated depreciation | ---- | ---- | 99.87%-13K | 99.87%-13K | ---- | ---- | ---- | -32.29%-9.81M | -32.29%-9.81M | ---- |
| Non current prepaid assets | ---- | ---- | --0 | --0 | --0 | -97.62%1K | 0.00%42K | 0.00%42K | 0.00%42K | -88.49%42K |
| Other non current assets | ---- | ---- | ---- | ---- | ---- | 0.00%500K | -20.13%500K | -20.76%500K | -20.76%500K | 24,900.00%500K |
| Total non current assets | --0 | --0 | -99.98%2K | -99.98%2K | -44.50%6.57M | -27.22%9.15M | -31.31%10.45M | -30.54%11.14M | -30.54%11.14M | -31.20%11.84M |
| Total assets | -83.25%4.68M | -87.59%6.04M | -87.28%8.26M | -87.28%8.26M | -71.13%19.44M | -62.23%27.93M | -42.77%48.64M | -31.55%64.94M | -31.55%64.94M | -40.80%67.34M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -75.32%365K | -56.74%597K | -55.65%616K | -55.65%616K | -34.58%1.3M | 212.03%1.48M | 128.10%1.38M | 1.54%1.39M | 1.54%1.39M | 35.61%1.98M |
| -accounts payable | -75.32%365K | -56.74%597K | -55.65%616K | -55.65%616K | -34.58%1.3M | 212.03%1.48M | 128.10%1.38M | 1.54%1.39M | 1.54%1.39M | 35.61%1.98M |
| Current accrued expenses | -83.24%542K | -84.39%643K | -69.80%1.3M | -69.80%1.3M | -59.99%3.07M | -43.51%3.23M | -30.06%4.12M | 3.37%4.29M | 3.37%4.29M | -45.03%7.68M |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | -98.68%307K | -98.35%339K | -21.54%11.56M | 101.50%17.32M | 101.50%17.32M | 82.08%23.21M |
| -Current debt | ---- | ---- | ---- | ---- | ---- | ---- | -21.48%10.99M | 113.08%16.77M | 113.08%16.77M | 88.32%22.67M |
| -Current capital lease obligation | ---- | ---- | --0 | --0 | -43.36%307K | -35.43%339K | -22.82%575K | -23.46%558K | -23.46%558K | -23.66%542K |
| Current liabilities | -82.05%907K | -92.73%1.24M | -91.91%1.96M | -91.91%1.96M | -85.77%4.68M | -81.13%5.05M | -19.64%17.06M | 50.65%24.17M | 50.65%24.17M | 16.67%32.87M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | --0 | --0 | -62.98%864K | -82.37%1.23M | -86.07%2.04M | -89.46%2.19M | -89.46%2.19M | -86.17%2.33M |
| -Long term capital lease obligation | ---- | ---- | --0 | --0 | -62.98%864K | -50.53%1.23M | -52.74%2.04M | -51.57%2.19M | -51.57%2.19M | -50.42%2.33M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --28K | 2,900.00%28K | 2,900.00%28K | --28K |
| Total non current liabilities | --0 | --0 | --0 | --0 | -63.42%864K | -82.44%1.23M | -85.88%2.07M | -89.33%2.22M | -89.33%2.22M | -86.01%2.36M |
| Total liabilities | -85.55%907K | -93.52%1.24M | -92.59%1.96M | -92.59%1.96M | -84.28%5.54M | -81.40%6.28M | -46.67%19.13M | -28.33%26.38M | -28.33%26.38M | -21.80%35.23M |
| Shareholders'equity | ||||||||||
| Share capital | -99.17%2K | -93.36%16K | 0.00%16K | 0.00%16K | 11.57%241K | 11.57%241K | 11.57%241K | -92.59%16K | -92.59%16K | 0.00%216K |
| -common stock | -99.17%2K | -93.36%16K | 0.00%16K | 0.00%16K | 11.57%241K | 11.57%241K | 11.57%241K | -92.59%16K | -92.59%16K | 0.00%216K |
| Retained earnings | -2.13%-918.58M | -3.01%-917.45M | -3.99%-915.77M | -3.99%-915.77M | -4.18%-907.92M | -4.28%-899.45M | -4.46%-890.68M | -4.48%-880.63M | -4.48%-880.63M | -4.86%-871.47M |
| Paid-in capital | 0.16%922.35M | 0.25%922.23M | 0.31%922.06M | 0.31%922.06M | 2.02%921.58M | 2.03%920.86M | 2.04%919.94M | 2.05%919.17M | 2.05%919.17M | 0.42%903.37M |
| Total stockholders'equity | -82.58%3.77M | -83.74%4.8M | -83.64%6.31M | -83.64%6.31M | -56.72%13.9M | -46.12%21.65M | -39.93%29.51M | -33.59%38.56M | -33.59%38.56M | -53.26%32.11M |
| Total equity | -82.58%3.77M | -83.74%4.8M | -83.64%6.31M | -83.64%6.31M | -56.72%13.9M | -46.12%21.65M | -39.93%29.51M | -33.59%38.56M | -33.59%38.56M | -53.26%32.11M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
